PDF下载 ( 363 KB)
Clinical guidelines for pediatric liver transplantation in China( 2015)
-
摘要:
<正>1前言儿童肝移植是临床肝移植的重要组成部分。自1963年世界首例儿童肝移植手术实施以来,经过半个世纪的发展,儿童肝移植的术后生存率已得到极大提高。在美国、日本等发达国家,儿童肝移植比例均超过肝移植总例数的10%,术后5年生存率约为80%,儿童活体肝移植的生存率则更高[1-2]。目前,国外儿童肝移植方面的指南有美国肝病学会与美国移植学会
-
Key words:
- liver transplantation /
- child /
- practice guideline
-
[1] United Network for Organ Sharing[DB/OL].http://www.unos.org/. [2]KASAHARA M,UMESHITA K,INOMATA Y,et al.Long-term outcomes of pediatric living donor liver transplantation in Japan:an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society[J].Am J Transplant,2013,13(7):1830-1839. [3]KELLY DA,BUCUVALAS JC,ALONSO EM,et al.Long-term medical management of the pediatric patient after liver transplantation:2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J].Liver Transpl,2013,19(8):798-825. [4]SQUIRES RH,NG V,ROMERO R,et al.Evaluation of the pediatric patient for liver transplantation:2014 practice guideline by the American Association for the Study of Liver Diseases,American Society of Transplantation and the North American Society for Pediatric Gastroenterology,Hepatology and Nutrition[J].Hepatology,2014,60(1):362-398. [5] GRADE working group[DB/OL].http://www.gradeworkinggroup.org/index.htm. [6] China Liver Transplant Registry.Scientific Report on Liver Transplantation in Children in 2011[EB/OL].http://www.cltr.org/.(in Chinese)中国肝移植注册.2011年儿童肝移植科学报告[EB/OL].http://www.cltr.org/. [7]FAGIUOLI S,DAINA E,D'ANTIGA L,et al.Monogenic diseases that can be cured by liver transplantation[J].J Hepatol,2013,59(3):595-612. [8] KERKAR N.Liver transplantation:a pediatric perspective[M]//AH-MAD J,FRIEDMAN SL,DANCYGIER H.Mount Sinai expert guides:Hepatology.Oxford:John Wiley&Sons,Ltd,2014:394-403. [9]AHMED A,KEEFFE EB.Current indications and contraindications for liver transplantation[J].Clin Liver Dis,2007,11(2):227-247. [10] Organ Procurement and Transplantation Network[DB/OL].http://optn.transplant.hrsa.gov/. [11]ARGUEDAS MR,ABRAMS GA,KROWKA MJ,et al.Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation[J].Hepatology,2003,37(1):192-197. [12]CONDINO AA,LVY DD,O'CONNOR JA,et al.Portopulmonary hypertension in pediatric patients[J].J Pediatr,2005,147(1):20-26. [13] KROWKA MJ,SWANSON KL,FRANTZ RP,et al.Portopulmonary hypertension:results from a 10-year screening algorithm[J].Hepatology,2006,44(6):1502-1510. [14]MILLER MR,SOKOL RJ,NARKEWICZ MR,et al.Pulmonary function in individuals who underwent liver transplantation:from the US cystic brosis foundation registry[J].Liver Transpl,2012,18(5):585-593. [15] SCHWARTZ GJ,MU OZ A,SCHNEIDER MF,et al.New equations to estimate GFR in children with CKD[J].J Am Soc Nephrol,2009,20(3):629-637. [16] FINNEY H,NEWMAN DJ,THAKKAR H,et al.Reference ranges for plasma cystatin C and creatinine measurements in premature infants,neonates,and older children[J].Arch Dis Child,2000,82(1):71-75. [17]SAMYN M,CHEESEMAN P,BEVIS L,et al.Cystatin C,an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation[J].Liver Transpl,2005,11(3):344-349. [18] SULTAN MI,LEON CD,BIANK VF.Role of nutrition in pediatric chronic liver disease[J].Nutr Clin Pract,2011,26(4):401-408. [19] SATHE MN,PATEL AS.Update in pediatrics:focus on fat-soluble vitamins[J].Nutr Clin Pract,2010,25(4):340-346. [20] SULLIVAN JS,SUNDARAM SS,PAN Z,et al.Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation[J].Liver Transpl,2012,18(1):120-128. [21]KALLER T,SCHULZ KH,SANDER K,et al.Cognitive abilities in children after liver transplantation[J].Transplantation,2005,79(9):1252-1256. [22]SORENSEN LG,NEIGHBORS K,MARTZ K,et al.Cognitive and academic outcomes after pediatric liver transplantation:Functional Outcomes Group(FOG)results[J].Am J Transpl,2011,11(2):303-311. [23] LYKAVIERIS P,CHARDOT C,SOKHN M,et al.Outcome in adulthood of biliary atresia:a study of 63 patients who survived for over 20 years with their native liver[J].Hepatology,2005,41(2):366-371. [24]SEDA NETO J,FEIER FH,BIERRENBACH AL,et al.Impact of Kasai portoenterostomy on liver transplantation outcomes:a retrospective cohort study of 347 children with biliary atresia[J].Liver Transpl,2015,21(7):922-927. [25] SOKOL RJ,SHEPHERD RW,SUPERINA R,et al.Screening and outcomes in biliary atresia:summary of a National Institues of Health wordshop[J].Hepatology,2007,46(2):566-581. [26] EMERICK KM,RAND EB,GOLDMUNTZ E,et al.Features of Alagille syndrome in 92 patients:frequency and relation to prognosis[J].Hepatology,1999,29(3):822-829. [27]KASAHARA M,SAKAMOTO S,HORIKAWA R,et al.Living donor liver transplantation for pediatric patients with metabolic disorders:the Japanese multicenter registry[J].Pediatr Transplant,2014,18(1):6-15. [28]MAZARIEGOS G,SHNEIDER B,BURTON B,et al.Liver transplantation for pediatric metabolic disease[J].Mol Genet Metab,2014,111(4):418-427. [29]LIU E,MACKENZIE T,DOBYNS EL,et al.Characterization of acute liver failure and development of a continuous risk of death staging system in children[J].J Hepatol,2006,44(1):134-141. [30]LU BR,ZHANG S,NARKEWICZ MR,et al.Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure[J].J Pediatr,2013,162(5):1010-1016. [31] ISMAIL H,BRONISZCZAK D,KALICISKI P,et al.Liver transplantation in children with hepatocellular carcinoma.Do Milan criteria apply to pediatric patients?[J].Pediatr Transplant,2009,13(6):682-692. [32] ROMANO F,STROPPA P,BRAVI M,et al.Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma[J].Pediatr Transplant,2011,15(6):573-579. [33]EGAWA H,OIKE F,BUHLER L,et al.Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation[J].Transplantation,2004,77(3):403-411. [34]OKADA N,SANADA Y,HIRATA Y,et al.The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation:the experience of a single center[J].Pediatr Transplant,2015,19(3):279-286. [35]SCHUKFEH N,LENZ V,METZELDER ML,et al.First case studies of successful ABO-incompatible living-related liver transplantation in infants in Germany[J].Eur J Pediatr Surg,2015,25(1):77-81. [36] POPESCU I,HABIB N,DIMA S,et al.Domino liver transplantation using a graft from a donor with familial hypercholesterolemia:seven-yr follow-up[J].Clin Transplant,2009,23(4):565-570. [37]LIU C,NIU DM,LOONG CC,et al.Domino liver graft from a patient with homozygous familial hypercholesterolemia[J].Pediatr Transplant,2010,14(3):e30-e33. [38] POPESCU I,DIMA SO.Domino liver transplantation:how far can we push the paradigm?[J].Liver Transpl,2012,18(1):22-28. [39]RELA M,MUIESAN P,ANDREANI P,et al.Auxiliary liver transplantation for metabolic diseases[J].Transplant Proc,1997,29(1-2):444-445. [40] ROSENTHAL P,ROBERTS JP,ASCHER NL,et al.Auxiliary liver transplant in fulminant failure[J].Pediatrics,1997,100(2):e10. [41] de GOYET JV,ROGIERS X,OTTE JB.Split-liver transplantation for the pediatric and adult recipient[M]//BUSUTTIL RW,KLINTMALM GK.Transplantation of the Liver.New York:Saunders,2005:609-627. [42]ACKERMANN O,BRANCHEREAU S,FRANCHI-ABELLA S,et al.The long-term outcome of hepatic artery thrombosis after liver transplantation in children:role of urgent revascularization[J].Am JTransplant,2012,12(6):1496-1503. [43]GU L,FANG H,LI F,et al.Impact of hepatic arterial hemodynamics in predicting early hepatic arterial thrombosis in pediatric recipients younger than three yr after living donor liver transplantation[J].Pediatr Transplant,2015,19(3):273-278. [44]GU LH,FANG H,LI FH,et al.Prediction of early hepatic artery thrombosis by intraoperative color Doppler ultrasound in pediatric segmental liver transplantation[J].Clin Transplant,2012,26(4):571-576. [45]WARNAAR N,POLAK WG,de JONG KP,et al.Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation[J].Liver Transpl,2010,16(7):847-855. [46]RODRGUEZ-CASTRO KI,PORTE RJ,NADAL E,et al.Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation:a systematic review[J].Transplantation,2012,94(11):1145-1153. [47]JENSEN MK,CAMPBELL KM,ALONSO MH,et al.Management and long-term consequences of portal vein thrombosis after liver transplantation in children[J].Liver Transpl,2013,19(3):315-321. [48]TAKATSUKI M,CHEN CL,CHEN YS,et al.Systemic thrombolytic therapy for late-onset portal vein thrombosis after living-donor liver transplantation[J].Transplantation,2004,77(7):1014-1018. [49]SOMMOVILLA J,DOYLE MM,VACHHARAJANI N,et al.Hepatic venous outflow obstruction in pediatric liver transplantation:technical considerations in prevention,diagnosis,and management[J].Pediatr Transplant,2014,18(5):497-502. [50]KO GY,SUNG KB,YOON HK,et al.Early posttransplant hepatic venous outflow obstruction:long-term efficacy of primary stent placement[J].Liver Transpl,2008,14(10):1505-1511. [51]DECHNE A,KODDE C,KATHEMANN S,et al.Endoscopic treatment of pediatric post-transplant biliary complications is safe and effective[J].Dig Endosc,2015,27(4):505-511. [52]LAURENCE JM,SAPISOCHIN G,DEANGELIS M,et al.Biliary complications in pediatric liver transplantation:incidence and management over a decade[J].Liver Transpl,2015,21(8):1082-1090. [53] SHARMA S,GURAKAR A,JABBOUR N.Biliary strictures following liver transplantation:past,present and preventive strategies[J].Liver Transpl,2008,14(6):759-769. [54]TANAKA H,FUKUDA A,SHIGETA T,et al.Biliary reconstruction in pediatric live donor liver transplantation:duct-to-duct or Rouxen-Y hepaticojejunostomy[J].J Pediatr Surg,2010,45(8):1668-1675. [55] HUMAR A,SNYDMAN D;AST Infectious Diseases Community of Practice.Cytomegalovirus in solid organ transplant recipients[J].Am J Transplant,2009,9(Suppl 4):s78-s86. [56] LJUNGMAN P,GRIFFITHS P,PAYA C.Definitions of cytomegalovirus infection and disease in transplant recipients[J].Clin Infect Dis,2002,34(8):1094-1097. [57]MADAN RP,CAMPBELL AL,SHUST GF,et al.A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients[J].Transplantation,2009,87(9):1318-1324. [58]DANZIGER-ISAKOV L,BUCAVALAS J.Current prevention strategies against cytomegalovirus in the studies in pediatric liver transplantation(SPLIT)centers[J].Am J Transplant,2014,14(8):1908-1911. [59]GREEN M,MICHAELS MG.Epstein-Barr virus infection and posttransplant lymphoproliferative disorder[J].Am J Transplant,2013,13(Suppl 3):41-54. [60]ALLEN UD,PREIKSAITIS JK;AST Infectious Diseases Community of Practice.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation[J].Am J Transplant,2013,13(Suppl 4):107-120. [61]NARKEWICZ MR,GREEN M,DUNN S,et al.Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients:report of the studies of pediatric liver transplantation experience[J].Liver Transpl,2013,19(7):730-740. [62]RESHEF R,VARDHANABHUTI S,LUSKIN MR,et al.Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder[J].Am J Transplant,2011,11(2):336-347. [63]XI ZF,XIA Q,ZHANG JJ,et al.De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation[J].J Dig Dis,2013,14(8):439-445. [64]RAO W,XIE M,YANG T,et al.Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation[J].World J Gastroenterol,2014,20(36):13159-13166. [65]JONAS MM,BLOCK JM,HABER BA,et al.Treatment of children with chronic hepatitis B virus infection in the United States:patient selection and therapeutic options[J].Hepatology,2010,52(6):2192-2205. [66]ALLERN U,GREEN M.Prevention and treatment of infectious complications after solid organ transplantation in children[J].Pediatr Clin North Am,2010,57(2):459-479. [67]KELLY D,JARA P,RODECK B,et al.Tacrolimus and steroids versus ciclosporin microemulsion,steroids,and azathioprine in children undergoing liver transplantation:randomized European multicentre trial[J].Lancet,2004,364(9439):1054-1061. [68] NH VL,FECTEAU A,SHEPHERD R,et al.Outcomes of 5-year survivors of pediatric liver transplantation:report on 461 children from a north americanmulticenter registry[J].Pediatrics,2008,122(6):e1128-e1135. [69]TAYLOR AL,GIBBS P,SUDHINDRAN S,et al.Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease afterliver transplantation[J].Transplantation,2004,77(3):441-446. [70]XUE F,HAN L,CHEN Y,et al.CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients[J].Pediatr Transplant,2014,18(2):166-176. [71] CHEN YK,HAN LZ,XUE F,et al.Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation[J].PLoSOne,2014,9(10):e109464. [72]KELLY D.Safety and efficacy of tacrolimus in pediatric liver recipients[J].Pediatr Transplant,2011,15(1):19-24. [73] GRAS JM,GERKENS S,BEGUIN C,et al.Steroid-free,tacrolimus-basiliximab immunosuppression in pediatric liver transplantation:clinical and pharmacoeconomic study in 50 children[J].Liver Transpl,2008,14(4):469-477. [74]TURNER AP,KNECHTLE SJ.Induction immunosuppression in liver transplantation:a review[J].Transpl Int,2013,26(7):673-683. [75] FENG S,EKONG UD,LOBRITTO SJ,et al.Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants[J].JA-MA,2012,307(3):283-293. [76]KOSHIBA T,LI Y,TAKEMURA M,et al.Clinical,immunological,and pathological aspects of operational tolerance after pediatric living---donor liver transplantation[J].Transpl Immunol,2007,17(2):94-97. [77]CAMPBELL K,NG V,MARTIN S,et al.SPLIT Renal Function Working Group.Glomerular filtration rate following pediatric liver transplantation-the SPLIT experience[J].Am J Transplant,2010,10(12):2673-2682. [78]ARORA-GUPTA N,DAVIES P,MCKIERNAN P,et al.The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation[J].Pediatr Transplant,2004,8(2):145-150. [79]MCLIN VA,ANAND R,DANIELS SR,et al.Blood pressure elevation in long-term survivors of pediatric liver transplantation[J].Am J Transplant,2012,12(1):183-190. [80] HATHOUT E,ALONSO E,ANAN R,et al.Posttransplant diabetes mellitus in pediatric liver transplantation[J].Pediatr Transplant,2009,13(5):599-605. [81]KUO HT,LAU C,SAMPAIO MS,et al.Pretransplant risk factors for new-onset diabetes mellitus after transplant in pediatric liver transplant recipients[J].Liver Transpl,2010,16(11):1249-1256. [82]MCDIARMID SV,GORNBEIN JA,DESILVA PJ,et al.Factors affecting growth after pediatric liver transplantation[J].Transplantation,1999,67(3):404-411. [83] ALONSO EM,SHEPHERD R,MARTZ KL,et al.Linear growth patterns in prepubertal children following liver transplantation[J].Am JTransplant,2009,9(6):1389-1397. [84]BARTOSH SM,THOMAS SE,SUTTON MM,et al.Linear growth after pediatric liver transplantation[J].J Pediatr,1999,135(5):624-631. [85] GILMOUR S,ADKINS R,LIDDELL GA,et al.Assessment of psychoeducational outcomes after pediatric liver transplant[J].Am J Transplant,2009,9(2):294-300. [86] MINTZER LL,STUBER ML,SEACORD D,et al.Traumatic stress symptoms in adolescent organ transplant recipients[J].Pediatrics,2005,115(6):1640-1644. [87] DANZINGER-ISAKOV L,KUMAR D;AST Infectious Diseases Community of Practice.Guidelines for vaccination of solid organ transplant candidates and recipients[J].Am J Transplant,2009,9(Suppl 4):s258-s262. [88] RUBIN LG,LEVIN MJ,LJUNGMAN P,et al.2013 IDSA clinica practice guideline for vaccination of the immunocompromised host[J].Clin Infect Dis,2014,58(3):309-318. [89] de BLESER L,DOBBELS F,BERBEN L,et al.The spectrum o non-adherence with medication in heart,liver,and lung transplan patients assessed in various ways[J].Transpl Int,2011,24(9):882-891. -
本文二维码
计量
- 文章访问数: 364
- HTML全文浏览量: 20
- PDF下载量: 584
- 被引次数: 0
下载:
